Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Dopamine D4 receptors in psychostimulant addiction.

Di Ciano P, Grandy DK, Le Foll B.

Adv Pharmacol. 2014;69:301-21. doi: 10.1016/B978-0-12-420118-7.00008-1. Review.

2.

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.

Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E.

J Neurosci. 2002 Apr 1;22(7):2977-88.

3.

Dopamine Dâ‚„ Receptor Antagonists for the Treatment of Cocaine Use Disorders.

Bergman J, Rheingold CG.

CNS Neurol Disord Drug Targets. 2015;14(6):707-15. Review.

PMID:
26022267
4.

Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.

Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR.

Trends Pharmacol Sci. 1997 Jun;18(6):186-8. Review.

PMID:
9226994
5.
6.

Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats.

Yan Y, Pushparaj A, Le Strat Y, Gamaleddin I, Barnes C, Justinova Z, Goldberg SR, Le Foll B.

Neuropsychopharmacology. 2012 Feb;37(3):685-96. doi: 10.1038/npp.2011.245. Epub 2011 Oct 26.

7.

Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.

Mamiya T, Matsumura T, Ukai M.

Ann N Y Acad Sci. 2004 Oct;1025:424-9.

PMID:
15542745
8.

Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, Skolnick P.

Int J Neuropsychopharmacol. 2013 Mar;16(2):445-58. doi: 10.1017/S1461145712000661. Epub 2012 Jul 25.

9.

D4 dopamine receptor-specific antagonist improves reversal learning impairment in amphetamine-treated male rats.

Connolly NP, Gomez-Serrano M.

Exp Clin Psychopharmacol. 2014 Dec;22(6):557-64. doi: 10.1037/a0038216. Epub 2014 Oct 20.

PMID:
25330246
10.

D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

Fan X, Xu M, Hess EJ.

Neurobiol Dis. 2010 Jan;37(1):228-36. doi: 10.1016/j.nbd.2009.10.009. Epub 2009 Oct 22.

11.

Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.

Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB.

Mol Pharmacol. 1996 Dec;50(6):1658-64.

PMID:
8967990
12.

The dopamine D4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline.

Costanza RM, Terry P.

Eur J Pharmacol. 1998 Mar 19;345(2):129-32.

PMID:
9600627
13.

L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.

Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD.

J Pharmacol Exp Ther. 1997 Dec;283(3):1256-63.

14.
15.

Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.

Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P.

Biochem Pharmacol. 2012 Oct 1;84(7):882-90. doi: 10.1016/j.bcp.2012.06.023. Epub 2012 Jul 3. Review.

17.

Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat.

Ukai M, Mitsunaga H.

Methods Find Exp Clin Pharmacol. 2005 Nov;27(9):645-9.

PMID:
16357950
18.

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Keck TM, John WS, Czoty PW, Nader MA, Newman AH.

J Med Chem. 2015 Jul 23;58(14):5361-80. doi: 10.1021/jm501512b. Epub 2015 Mar 31.

19.

Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.

Mason CW, Hassan HE, Kim KP, Cao J, Eddington ND, Newman AH, Voulalas PJ.

J Pharmacol Exp Ther. 2010 Jun;333(3):854-64. doi: 10.1124/jpet.109.165084. Epub 2010 Mar 12.

20.

Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.

Thanos PK, Bermeo C, Rubinstein M, Suchland KL, Wang GJ, Grandy DK, Volkow ND.

J Psychopharmacol. 2010 Jun;24(6):897-904. doi: 10.1177/0269881109102613. Epub 2009 Mar 12.

Supplemental Content

Support Center